Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 301
Appendix C
Committee Member and
Staff Biographies
COMMITTEE MEMBER BIOGRAPHIES
Lawrence O. Gostin, J.D. (Chair) is an internationally recognized scholar in
law and public health. He is an elected member of the Institute of Medicine
of the National Academies and an elected fellow of the Hastings Center. At
the National Academies, he has served on the Board on Population Health
and Public Health Practice, as well as many committees, including as Chair
of the Committee on Genomics and the Public’s Health in the 21st Century
and Chair of the Committee on Ethical Considerations for Revisions to
HHS Regulations for Protection of Prisoners Involved in Research. Profes-
sor Gostin is the Health Law and Ethics Editor of the Journal of the Ameri-
can Medical Association and serves on the editorial boards of many other
scholarly journals. His recent books have included: The AIDS Pandemic:
Complacency, Injustice, and Unfulfilled Expectations (2004), The Human
Rights of Persons with Intellectual Disabilities: Different But Equal (2003,
with S. S. Herr, H. H. Koh, eds.), Public Health Law and Ethics: A Reader
(2002), and Public Health Law: Power, Duty, Restraint (2000). He cur-
rently works as a Professor of Public Health at Johns Hopkins University,
and as Professor of Law and Director of the Center on Law and the Public’s
Health at the Georgetown University Law Center.
Paul S. Appelbaum, M.D., is the Elizabeth K. Dollard Professor of
Psychiatry, Medicine, and Law, and Director, Division of Psychiatry, Law,
and Ethics, Department of Psychiatry, College of Physicians and Surgeons
of Columbia University. He is the author of many articles and books on
0
OCR for page 302
0 BEYOND THE HIPAA PRIVACY RULE
law and ethics in clinical practice, including four that were awarded the
Manfred S. Guttmacher Award from the American Psychiatric Association
and the American Academy of Psychiatry and the Law. Dr. Appelbaum is
Past President of the American Psychiatric Association, the American Acad-
emy of Psychiatry and the Law, and the Massachusetts Psychiatric Society,
and serves as Chair of the Council on Psychiatry and Law for the American
Psychiatric Association. He was previously Chair of the Commission on
Judicial Action for the American Psychiatric Association and a member of
the MacArthur Foundation Research Network on Mental Health and the
Law. He is currently a member of the MacArthur Foundation Network on
Mandatory Outpatient Treatment. He has received the Isaac Ray Award
of the American Psychiatric Association for “outstanding contributions to
forensic psychiatry and the psychiatric aspects of jurisprudence,” was the
Fritz Redlich Fellow at the Center for Advanced Study in the Behavioral
Sciences, and has been elected to the Institute of Medicine. Dr. Appelbaum
is a graduate of Columbia College, received his M.D. from Harvard Medi-
cal School, and completed his residency in psychiatry at the Massachusetts
Mental Health Center in Boston.
Elizabeth Beattie, Ph.D., is a Professor, School of Nursing, Faculty of Health
Sciences, The Queensland University of Technology. She was formerly a
Research Compliance Associate at the Office of Human Research Compli-
ance Review, University of Michigan, and an Adjunct Associate Professor
in the Adult and Gerontology Nursing Program, University of Iowa. In her
former role in regulatory affairs she was involved in compliance monitoring
activities with human research studies in many disciplines, and in human
subjects protection education and research. Prior to these positions, she
was research faculty at the School of Nursing, University of Michigan.
Her primary role was Project Director for several large multisite federally-
funded projects focused on wandering behavior associated with dementia
in long term care residents. As Project Director, she coordinated all aspects
of the projects, including Institutional Review Board and Special Project
Assurance requirements, site access, subject recruitment and informed con-
sent procedures, research team training, data collection, and data coding.
She served on the Institutional Review Board for Health Sciences for over
3 years. She was formally tenured foundation faculty in Australia at two
new schools of nursing: The University of Technology and James Cook Uni-
versity. Dr. Beattie received her Ph.D. (Nursing Science) in a unique arrange-
ment between the University of Michigan School of Nursing and James
Cook University in Australia, and completed a fellowship at the Hartford
Institute for Gerontological Nursing Research Summer Institute, New York
University. She completed her Advanced Psychiatric Nursing Certificate at
OCR for page 303
0
APPENDIX C
the Bethlem Royal and Maudsley hospitals, London, United Kingdom. Dr.
Beattie is a Fellow of the Gerontological Society of America.
Marc Boutin, J.D., is the Executive Vice President at the National Health
Council, an umbrella organization representing approximately 100 million
people with chronic conditions. The Council promotes health care for all
people, the importance of medical research, and the role of patient-based
groups. Throughout Mr. Boutin’s career, he has been highly involved in
health advocacy, policy, and legislation. He has designed and directed
numerous strategies for issues ranging from access to health care to cancer
prevention. Before joining the Council, Mr. Boutin served as the Vice Presi-
dent of Government Relations and Advocacy at the American Cancer Soci-
ety for New England and was a faculty member at Tufts University Medical
School. In addition to senior government relations positions at Easter Seals
and the Massachusetts Association of Health Boards, he was a civil rights
litigator. Mr. Boutin received his Bsc. Econ. in International Politics/Law
from the University College of Wales, Aberystwyth, United Kingdom, in
1989, and his J.D. from Suffolk University Law School in 1994.
Thomas W. Croghan, M.D., is a Senior Fellow at Mathematica Policy
Research, Inc., where his research concentrates on studying health care
access and quality, adequacy of coverage, and outcomes for different groups,
in addition to analyzing the capabilities of the health system to provide care
for vulnerable populations. Dr. Croghan received his M.D. from West Vir-
ginia University School of Medicine and undertook postdoctoral training
at Johns Hopkins University and Stanford University. Prior to his position
at Mathematica, he was a Senior Natural Scientist at the RAND Corpora-
tion. He has directed many studies of health care access, quality, cost, and
cost-effectiveness of medical treatments, including projects for the National
Institutes of Health, Center for Multicultural Mental Health Research,
U.S. Department of the Army, National Defense Research Institute, and Eli
Lilly and Company. While at Lilly, he founded the Department of Health
Services and Policy Research and served as Principal Project Officer for a
National Bureau of Economic Research project that created price indexes
for the treatment of depression and other conditions. He also initiated the
Schizophrenia Care and Assessment Program, a prospective observational
study of 2,400 persons with severe psychosis. In 1999, he received a Robert
Wood Johnson Foundation Investigator Award in Health Policy Research
for conceptualizing the social, economic, and cultural issues underlying
health care outcomes. He has published widely and serves as a reviewer
for many publications, including Health Services Research, Health Affairs,
Archives of General Psychiatry, and the American Journal of Managed
OCR for page 304
0 BEYOND THE HIPAA PRIVACY RULE
Care. Board certified in internal medicine and rheumatology, Dr. Croghan
practices primary care medicine at the Washington Free Clinic.
Stanley W. Crosley, Esq., is Chief Privacy Officer at Eli Lilly and Company.
Mr. Crosley initiated Lilly’s global privacy program, and he currently over-
sees the company’s privacy program on a global basis across all company
functions. He is a co-founder and Chairman of the Board of Directors of
the International Pharmaceutical Privacy Consortium (IPPC) and is on the
Executive Committee of the Center for Information Policy Leadership. He
also sits on the Conference Board’s Chief Privacy Officers Council. Prior
to his arrival at Lilly, Mr. Crosley worked at Armstrong Teasdale Schlafly
& Davis in St. Louis, and at Ice Miller Donadio & Ryan where he concen-
trated on technology, privacy, and eBusiness. Mr. Crosley earned his B.S.
in Biology, with a minor in Chemistry, from Hillsdale College and his J.D.
from Indiana University.
Sandra J. Horning, M.D., is Professor of Medicine (Oncology and Bone
Marrow Transplantation) at Stanford University School of Medicine in
Stanford, California. She chairs the Lymphoma Committee of the Eastern
Cooperative Oncology Group (ECOG), serving as senior investigator for
multiple Phase II and III clinical trials. Her patient-oriented research in
Hodgkin’s disease and lymphoma is supported by National Institutes of
Health (NIH) and other peer-reviewed funding. Dr. Horning is active in a
number of professional societies including the American Society of Clinical
Oncology, where she is the Immediate Past President. She is a member of
the NCI Clinical Trials Advisory Committee to the Director of the National
Cancer Institute and served as a member of the NIH Clinical Oncology
Study Section. Dr. Horning chairs the Scientific Review Committee at Stan-
ford Cancer Center and she co-leads the program in lymphoma for the
Cancer Center. She lectures nationally and internationally and serves on
the steering committees for several international consortia. An advocate
of new drug development, Dr. Horning has served on the Oncology Drug
Advisory Board for the Federal Drug Administration. She currently serves
on the editorial boards of Annals of Internal Medicine, Leukemia and
Lymphoma, Clinical Lymphoma, and C.U.R.E. Dr. Horning earned her
medical degree at the University of Iowa, after which she completed inter-
nal medicine training at the University of Rochester. She also completed a
medical oncology fellowship at Stanford University.
James S. Jackson, Ph.D., is a Daniel Katz Distinguished University Professor
of Psychology, Professor of Health Behavior and Health Education, School
of Public Health, and Director of the Institute for Social Research; past
Director of the Research Center for Group Dynamics, past Director of the
OCR for page 305
0
APPENDIX C
Program for Research on Black Americans, and past Director of the Center
for Afroamerican and African Studies, all at the University of Michigan.
He is past-Chair of the Section on Social, Economic, and Political Sci-
ences of the American Association for the Advancement of Science (AAAS).
He is a former Chair of the Section on Social and Behavioral Sciences and
the Task Force on Minority Issues of the Gerontological Society of America,
Committee on International Relations; Association for the Advancement of
Psychology, and American Psychological Association. He was a recipient
of a Fogarty Senior Postdoctoral International Fellowship, 1993–1994,
for study in France and Western Europe. He has conducted research and
published numerous books, scientific articles, and chapters on international,
comparative studies on immigration, race and ethnic relations, physical and
mental health, adult development and aging, attitudes and attitude change,
and African American politics. He is former National President of the Black
Students Psychological Association and the Association of Black Psycholo-
gists. He is a Fellow of the Gerontological Society of America, the American
Psychological Association, the Association of Psychological Sciences, and
the American Association for the Advancement of Science. He is an elected
a member of the Institute of Medicine.
Dr. Jackson has been the principal investigator of more than two
dozen NIH-funded and National Science Foundation (NSF) grants. He
is currently directing the most-extensive social, political behavior, and
health surveys on the American and Caribbean populations ever conducted;
the National Institute of Mental Health, the National Institute on Aging,
and the National Institute on Drug Abuse supported “National Survey of
American Life” and “Family Survey Across Generations and Nations,” and
NSF-supported “National Study of Ethnic Pluralism and Politics.”
Mary Beth Joublanc, J.D., is the Chief Privacy Officer for the State of
Arizona, Arizona Government Technology Agency. She was formerly the
Chief HIPAA Compliance Officer for the Arizona Department of Health
Services, Phoenix, Arizona. She is also the Chair for the Department’s
Human Subjects Research Board. Ms. Joublanc is an active member of the
State Bar of Arizona. Her legal practice focuses on regulatory compliance,
health care law, risk management, and professional liability claims manage-
ment. Ms. Joublanc has lectured on a variety of topics related to health law
and risk management. She holds a B.S. in Health Information and, prior to
law school, was a health information manager with experience in primary,
secondary, and tertiary care.
Bernard Lo, M.D., is Professor of Medicine and Director of the Program
in Medical Ethics at the University of California, San Francisco (UCSF).
He is National Program Director for the Greenwall Faculty Scholars Pro-
OCR for page 306
0 BEYOND THE HIPAA PRIVACY RULE
gram in Bioethics. He is Co-Chair of the Standards Working Group of
the California Institute of Regenerative Medicine, which will recommend
regulations for stem cell research funded by the state of California. He
also serves on the Data and Safety Monitoring Committees for diabetes
prevention trials and a HIV vaccine trial at the National Institute of Allergy
and Infectious Disease. He is a member of the Ethics Working Group of
the NIH-sponsorsed HIV Prevention Trials Network, which carries out
clinical trials in developing countries. Dr. Lo is Co-Director of the Policy
and Ethics Core of the Center for AIDS Prevention Studies at UCSF, which
provides technical advice and consultation to researchers carrying out clini-
cal research, including research in resource-poor nations. He is a member
of the IOM and serves on the IOM Council. He has been involved in a
number of studies on ethical issues in human participants research carried
out by the IOM and the National Academy of Science (NAS). He chaired
an IOM panel on confidentiality in health services research. He developed
a course on Responsible Conduct of Research that 120 postdoctoral fellows
and junior faculty take each year. He also carries out research on ethical
issues in human participants research, end-of-life decisions, and stem cell
research. He is a practicing general internist and attends on the inpatient
medical service at UCSF.
Andrew F. Nelson, M.P.H., is Executive Director of the HealthPartners
Research Foundation and Vice President of HealthPartners. Mr. Nelson
has provided leadership for this nonprofit, medical/health care research
organization since its inception in 1990. He also serves as a Corporate
Officer for HealthPartners, Inc. HealthPartners is an integrated health
delivery system servicing over 725,000 people in Minnesota through a
medical group of 650 providers, a large clinic system, and a 450-bed
hospital. HealthPartners Research Foundation conducts more than 200
laboratory, clinical, and health services research projects annually, through
90 full-time staff, 25 full-time career researchers, and more than 45 clini-
cal researchers. More than 350 of HealthPartners 10,000 employees are
engaged in research and represent a broad array of medical, scientific, and
administrative disciplines.
Prior to the HealthPartners Research Foundation position, Mr. Nelson
was a Research Development Officer for the University of Minnesota’s
Health Sciences and Executive Director of the Day Community and Con-
nections Programs at the University of Minnesota’s programs that serve
emotionally and behaviorally disturbed adolescents. Mr. Nelson is a found-
ing member and serves as Immediate Past Chair of the Board of Directors
for the HMO Research Network, 15 research organizations with funding
of more than $100 million. He serves on a wide range of professional and
community committees and boards.
OCR for page 307
0
APPENDIX C
Marc Rotenberg, J.D., is president of the Electronic Privacy Information
Center and Adjunct Professor of Law, Georgetown Law. He was counsel to
Senator Patrick J. Leahy on the Senate Judiciary Committee, specializing in
technology and law. Professor Rotenberg has testified before Congress on
many issues, including access to information, computer crime, computer
security, and privacy. In 2003, he testified before the 9-11 Commission
on Security and Liberty. He is the Editor (with Daniel J. Solove and Paul
Schwartz) of Information Privacy Law (Aspen Publishing, 2006), is the Edi-
tor (with Phil Agre) of Technology and Privacy: The New Landscape (MIT
Press, 1998), The Privacy Law Sourcebook: United States Law, Interna-
tional Law and Recent Developments (Epic, 2005), and is on the editorial
boards of BNA Electronic Commerce and Law and Computer Law and
Security Reporter. Professor Rotenberg has served on advisory panels for
the American Bar Association Section on Criminal Justice, the American
Association for the Advancement of Science, the Austrian Institute for Law
and Policy, the National Academy of Sciences, UNESCO, and the Organiza-
tion for Economic Cooperation and Development. He chairs the American
Bar Association Committee on Privacy and Information Protection. He is
also Former Chair of the Public Interest Registry, which manages .ORG
domain. He was a Teaching Fellow in computer science at Harvard Univer-
sity from 1980 to 1982 and an instructor at Stanford University from 1986
to 1987. He received his A.B. cum laude from Harvard University and his
J.D. from Stanford University.
Wendy Visscher, Ph.D., is Director of RTI International’s Office of Research
Protection and Ethics, where she oversees the operation of the three Insti-
tutional Review Boards and chairs one of these committees. She maintains
RTI’s Federalwide Assurance with HHS’s Office for Human Research Pro-
tections. She earned her Certified IRB Professional rating in 2002. In addi-
tion to her knowledge of human subjects protection, Dr. Visscher trains
researchers on HIPAA and other data privacy requirements and regulations,
and consults with RTI management on these and related issues. Dr. Visscher
is also a trained epidemiologist with more than 20 years of health research
experience. Her areas of expertise include: heart disease and diabetes in
minority communities, drug use in pregnant women, children’s mental
health, global burden of influenza, HIV, reproductive epidemiology, radia-
tion and cancer, and patient outcomes studies. She received her Ph.D. in
1987 from the University of Minnesota.
Fred Wright, M.D., has served as Associate Chief of Staff for Research
(director of the research program) since 1984. He is a Staff Physician at the
VA Connecticut Healthcare System and has also been Acting Chief of Staff
in 1995 and 1998. He is a Professor in the Departments of Internal Medi-
OCR for page 308
0 BEYOND THE HIPAA PRIVACY RULE
cine and Cellular & Molecular Physiology at the Yale University School
of Medicine. Dr. Wright received his A.B. and M.D. from the University
of Michigan. He trained as a resident in medicine at the Johns Hopkins
Hospital in Baltimore and as a postdoctoral trainee in kidney physiology
at the National Institutes of Health in Bethesda, Maryland. He was then
appointed to the faculty at Yale University where his research continued
to focus on the structure and function of the kidney, with an emphasis on
mechanisms of ion transport by kidney tubules in health and disease. He
joined the medical staff at the West Haven VA Medical Center in 1997 and
continued to be involved in laboratory research and teaching of medical
students and advanced trainees.
Clyde W. Yancy, M.D., is a cardiologist and heart failure/heart transplant
specialist at Baylor University Medical Center at Dallas, where he is the
medical director of the Baylor Heart and Vascular Institute, and chief
of cardiothoracic transplantation at Baylor University Medical Center at
Dallas. Previously, Dr. Yancy was a professor of internal medicine and
cardiology and holder of the Carl Westcott Chair in Medical Research at
the University of Texas Southwestern Medical Center in Dallas where he
served as director of its heart transplant program. He also is credited with
establishing the medical center’s heart failure program and cardiovascular
institute. He holds fellowships in the American College of Cardiology, the
American Heart Association, and the American College of Physicians. He is
an active member of the American Heart Association, the American College
of Cardiology, the International Society of Heart and Lung Transplanta-
tion, and the American Society of Hypertension. Presently, he serves on the
executive committee of the Heart Failure Society of America. He also sits
on the editorial board of a number of professional journals. In 2003, he
was recognized as physician of the year by the American Heart Association
for leadership in programs related to its mission. He currently serves on the
Cardiovascular Device Panel for the Food and Drug Administration and is
a consultant to the National Heart, Lung, and Blood Institute. His research
interests include the broad areas of heart transplantation, heart failure,
and heart disease in special populations. Dr. Yancy received his M.D. from
Tulane University School of Medicine and completed post-graduate training
at the University of Texas Southwestern Medical Center.
STAFF BIOGRAPHIES
Sharyl Nass, Ph.D., is a Study Director and Senior Program Officer at the
Institute of Medicine, where she has worked with the Board on Health
Sciences Policy, Board on Health Care Services, and the National Cancer
Policy Board and Forum. Her previous work at the IOM has focused
OCR for page 309
0
APPENDIX C
on topics that include developing cancer biomarkers, strategies for large-
scale biomedical science, developing technologies for the early detection of
breast cancer, improving breast imaging quality standards, and contracep-
tive research and development. Her current position at the IOM combines
her dual interests in biomedical research and health science policy. With a
Ph.D. in Cell and Tumor Biology from Georgetown University and post-
doctoral training at the Johns Hopkins University School of Medicine, she
has authored numerous papers on the cell and molecular biology of breast
cancer. She also holds a B.S. in Genetics and an M.S. in Endocrinology/
Reproductive Physiology, both from the University of Wisconsin–Madison.
In addition, she studied developmental genetics and molecular biology at
the Max Planck Institute in Germany under a fellowship from Fulbright and
the German Heinrich Hertz-Stiftung Foundation. Dr. Nass was the 2007
recipient of the Cecil Award for Excellence in Health Policy Research.
Laura Levit, J.D., is an Associate Program Officer for the Board on Health
Care Services and the National Cancer Policy Forum. She started at the
IOM as a Christine Mirzayan Science and Technology Graduate Fellow in
winter 2007. In 2007, she received the IOM rookie award for her work
with the National Cancer Policy Forum. She graduated from the University
of Virginia School of Law in May 2006, and was admitted into the Virginia
Bar Association in October 2006. She completed her undergraduate studies
at the College of William and Mary, receiving a B.S. in Psychology. In law
school, Ms. Levit worked for several different nonprofit organizations that
focused on health and mental health care policy, including the World Fed-
eration for Mental Health, the Treatment Advocacy Center, the Bazelon
Center, and the National Research Center for Women & Families.
Roger Herdman, M.D., received his undergraduate and medical school
degrees from Yale University. Following an internship at the University of
Minnesota and a stint in the U.S. Navy, he returned to Minnesota where
he completed a residency in pediatrics and a fellowship in immunology and
nephrology and served on the faculty at the University of Minnesota. He
served as Professor of Pediatrics at Albany Medical College until 1979.
In 1969, Dr. Herdman was appointed Director of the New York State
Kidney Disease Institute in Albany, New York, and shortly thereafter was
appointed Deputy Commissioner of the New York State Department of
Health (1969–1977) and in 1977 was named New York State’s Director of
Public Health. From 1979 until joining the U.S. Congress’s Office of Tech-
nology Assessment (OTA), he served as a Vice President of the Memorial
Sloan-Kettering Cancer Center in New York City.
In December 1983, Dr. Herdman was named Assistant Director of OTA
where he subsequently served as Director (1993–1996). He later joined the
OCR for page 310
0 BEYOND THE HIPAA PRIVACY RULE
IOM as a Senior Scholar and directed studies on graduate medical educa-
tion, organ transplantation, silicone breast implants, and the Veterans
Administration national formulary. Dr. Herdman was appointed Director
of the IOM/National Research Council National Cancer Policy Board
from August 2000 through April 2005. Beginning in May 2005, he has
directed the IOM National Cancer Policy Forum, which includes federal
and private-sector cancer relevant agencies or organizations in addition
to academic/industry members. In October 2007, he was also appointed
Director of the IOM Board on Health Care Services. During his work at the
IOM, Dr. Herdman has worked closely with the U.S. Congress on a wide
variety of health care policy issues.
Andrew Pope, Ph.D., is Director of the IOM Board on Health Sciences
Policy. He has a Ph.D. in Physiology and Biochemistry from the University
of Maryland and has been a member of the National Academies staff since
1982 and of the IOM staff since 1989. His primary interests are science
policy, biomedical ethics, and environmental and occupational influences
on human health. During his tenure at the National Academies, Dr. Pope
has directed numerous studies on topics that range from injury control,
disability prevention, and biologic markers to the protection of human
subjects of research, NIH priority-setting processes, organ procurement and
transplantation policy, and the role of science and technology in counter-
ing terrorism. Dr. Pope is the recipient of IOM’s Cecil Award and the NAS
President’s Special Achievement Award.
Michael Park is a Senior Program Assistant for the Board on Health Care
Services and the National Cancer Policy Forum. Before arriving at the
IOM in September of 2007, Mr. Park worked for the National Academy of
Education and the International Law Group in Washington, DC. He earned
his B.A. in German and Italian Studies from the University of Maryland at
College Park. He is fluent in Spanish, Italian, and German.
